VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $403,650 | -13.2% | 15,000 | -2.9% | 0.03% | -13.5% |
| Q2 2023 | $465,290 | -6.9% | 15,453 | 0.0% | 0.04% | -15.9% |
| Q1 2023 | $499,905 | +1.4% | 15,453 | -24.4% | 0.04% | -34.3% |
| Q3 2022 | $493,000 | -12.0% | 20,453 | 0.0% | 0.07% | -23.0% |
| Q2 2022 | $560,000 | -42.3% | 20,453 | -19.2% | 0.09% | -34.6% |
| Q1 2022 | $971,000 | -0.2% | 25,307 | -23.3% | 0.13% | -7.0% |
| Q3 2021 | $973,000 | -13.2% | 33,000 | 0.0% | 0.14% | -13.9% |
| Q2 2021 | $1,121,000 | +4.5% | 33,000 | 0.0% | 0.17% | -32.0% |
| Q1 2021 | $1,073,000 | +164.3% | 33,000 | +192.9% | 0.24% | +248.6% |
| Q4 2020 | $406,000 | +3.6% | 11,267 | +12.7% | 0.07% | -7.9% |
| Q3 2020 | $392,000 | – | 10,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |